Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions

被引：3
|
作者：
Wang, Norman C. [1 ]
Piccini, Jonathan P. [2 ]
Gheorghiade, Mihai [3 ]
机构：
[1] Univ Pittsburgh, Cardiovasc Inst, Med Ctr, Pittsburgh, PA 15213 USA
[2] Duke Clin Res Ctr, Durham, NC USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
HEART FAILURE REVIEWS | 2011年 / 16卷 / 05期
关键词：
Implantable cardioverter-defibrillator; Heart failure; Hospitalization; Mortality; VENTRICULAR EJECTION FRACTION; MYOCARDIAL-INFARCTION; SURVIVAL; HOSPITALIZATION; DEATH;
D O I：
10.1007/s10741-011-9243-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Implantable cardioverter-defibrillators have proven efficacy in reducing mortality in patients with reduced left ventricular ejection fraction in both the primary and the secondary prevention settings. All randomized trials demonstrating this benefit have been conducted in outpatients with stable heart failure symptoms. Whether implantable cardioverter-defibrillators confer a benefit when implemented in patients with chronically reduced left ventricular ejection fraction in the acute heart failure setting is unknown. The purpose of this document is to review the existing literature related to this subject.
引用
收藏
页码：477 / 480
页数：4
相关论文
共 50 条
  • [41] MORTALITY BENEFITS AND THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    SWEENEY, MO
    RUSKIN, JN
    CIRCULATION, 1994, 89 (04) : 1851 - 1858
  • [42] Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter-defibrillator
    Bruch, Christian
    Bruch, Chahrebanu
    Sindermann, Juergen
    Breithardt, Guenter
    Gradaus, Rainer
    EUROPACE, 2007, 9 (08): : 681 - 686
  • [43] Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads
    Borleffs, C. Jan Willem
    van Erven, Lieselot
    van Bommel, Rutger J.
    van der Velde, Enno T.
    van der Wall, Ernst E.
    Bax, Jeroen J.
    Rosendaal, Frits R.
    Schalij, Martin J.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (04) : 411 - 416
  • [44] Development of the Implantable Cardioverter-Defibrillator
    Maron, Barry J.
    Estes, N. A. Mark
    Rowin, Ethan J.
    Maron, Martin S.
    Reynolds, Matthew R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (04) : 353 - 373
  • [45] The subcutaneous implantable cardioverter-defibrillator
    Grace, Andrew
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (01) : 10 - 19
  • [46] Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation
    Zareba, Wojciech
    Steinberg, Jonathan S.
    McNitt, Scott
    Daubert, James P.
    Piotrowicz, Katarzyna
    Moss, Arthur J.
    HEART RHYTHM, 2006, 3 (06) : 631 - 637
  • [47] Benefits of the implantable cardioverter-defibrillator
    Epstein, Andrew E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (14) : 1122 - 1127
  • [48] The effect of implantable cardioverter-defibrillator in patients with diabetes and non-ischaemic systolic heart failure
    Rorth, Rasmus
    Thune, Jens Jakob
    Nielsen, Jens C.
    Haarbo, Jens
    Videbaek, Lars
    Korup, Eva
    Signorovitch, James
    Bruun, Niels E.
    Eiskjaer, Hans
    Hassager, Christian
    Svendsen, Jesper Hastrup
    Hofsten, Dan E.
    Torp-Pedersen, Christian
    Pehrson, Steen
    Kober, Lars
    Kristensen, Soren L.
    EUROPACE, 2019, 21 (08): : 1203 - 1210
  • [49] The prevalence of implantable cardioverter-defibrillator (ICD) and heart failure patients eligible for remote monitoring in Germany
    Schwab, Jorg Otto
    Gricar, Boye
    Hauser, Tino
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):
  • [50] Twiddling with an implantable cardioverter-defibrillator
    McCann, Conor J.
    Beelen, Roel
    Geelen, Peter
    ACTA CARDIOLOGICA, 2009, 64 (05) : 695 - 695
12345